Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07
Top Cited Papers
- 15 March 2003
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (6), 1044-1049
- https://doi.org/10.1200/jco.2003.03.036
Abstract
Purpose: A multicenter, phase II study of single-agent, intravenous methotrexate in newly diagnosed non-AIDS-related primary CNS lymphoma was conducted in the New Approaches to Brain Tumor Therapy ...Keywords
This publication has 27 references indexed in Scilit:
- Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS LymphomaJournal of Clinical Oncology, 2000
- Electrophysiologic testing of neuromuscular transmissionNeurology, 1997
- Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?International Journal of Radiation Oncology*Biology*Physics, 1995
- Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcomeJournal of Neurosurgery, 1994
- Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary dataZeitschrift für Neurologie, 1993
- Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315International Journal of Radiation Oncology*Biology*Physics, 1992
- Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy aloneInternational Journal of Radiation Oncology*Biology*Physics, 1990
- High-dose methotrexate for non-AIDS primary central nervous system lymphomaJournal of Neurosurgery, 1989
- Increasing incidence of primary brain lymphoma in the USCancer, 1988
- Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival.Journal of Clinical Oncology, 1985